LI
JAZZ icon

LRI Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

LRI Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.9K Sell
336
-5
-1% -$1.09K 0.01% 479
2026
Q1 		$64.4K Buy
341
+120
+54% +$21K 0.01% 476
2025
Q4 		$37.6K Buy
+221
New +$33.9K ﹤0.01% 593

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

LRI Investments's JAZZ Position: Q2 2026 in Review

LRI Investments reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.5% in Q2 2026, selling an estimated $1.09K and leaving 336 shares worth $80.9K. The position accounts for 0.01% of the portfolio, ranked #479.

LRI Investments first reported a position in JAZZ in Q4 2025 and has held it in 3 quarters since. 333 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • LRI Investments held 336 shares of Jazz Pharmaceuticals worth $80.9K as of Q2 2026.
  • LRI Investments sold 5 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.09K.
  • Jazz Pharmaceuticals made up 0.01% of LRI Investments's portfolio in Q2 2026, its #479 holding.
  • LRI Investments first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 333 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.